fbpx
February 25, 2025

How Carbon, an industrial-scale 3D printing startup worth $2.4B, is scrambling to design and produce FDA-approved medical equipment for the COVID-19 response (Amy Feldman/Forbes)

i27.jpg

pml.png Amy Feldman / Forbes:
How Carbon, an industrial-scale 3D printing startup worth $2.4B, is scrambling to design and produce FDA-approved medical equipment for the COVID-19 response  —  Cover photo of Carbon’s prototype COVID-19 test swabs.  All but one of the designs passed patient testing at Stanford and Beth Israel hospitals …

This article was first featured at https://ift.tt/2R0TDxZ on March 25, 2020 at 03:57PM by

%d bloggers like this: